FR2442053A2 - Increasing antibacterial activity of cephalosporin derivs. - by combining with beta lactamase inhibiting penicillanic-S,S-di:oxide - Google Patents
Increasing antibacterial activity of cephalosporin derivs. - by combining with beta lactamase inhibiting penicillanic-S,S-di:oxideInfo
- Publication number
- FR2442053A2 FR2442053A2 FR7917043A FR7917043A FR2442053A2 FR 2442053 A2 FR2442053 A2 FR 2442053A2 FR 7917043 A FR7917043 A FR 7917043A FR 7917043 A FR7917043 A FR 7917043A FR 2442053 A2 FR2442053 A2 FR 2442053A2
- Authority
- FR
- France
- Prior art keywords
- penicillanic
- combining
- oxide
- antibacterial activity
- beta lactamase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
The antibacterial effect of 7-(D-2- 4-ethylpiperazine-2,3-dione-1-carboxamido -2- 4-hydroxyph- enyl acetamido -3-(1-methyl-5-tetrazolyl thiomethyl)-3-deactoxyme- thyl-cephalosporamic acid (I) or its salts, is increased by combining it with a penicillanic-5,5-dioxide of formula (II) or its salts with bases. In the formulae, R1 is H or residue completing an ester which is easily hydrolysed in vivo. (I) is a known antibacterial. (II) are antibacterials and beta-lactamase inhibitors. The mixt. of (I) and (II) are useful esp. against ampicillin resistant strains of E. Coli and Bacteriods spp, and are effective at lower doses than either component individually.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80432077A | 1977-06-07 | 1977-06-07 | |
US87938178A | 1978-02-21 | 1978-02-21 | |
US89045178A | 1978-03-29 | 1978-03-29 | |
US96376378A | 1978-11-27 | 1978-11-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2442053A2 true FR2442053A2 (en) | 1980-06-20 |
FR2442053B2 FR2442053B2 (en) | 1982-12-10 |
Family
ID=27505824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7917043A Granted FR2442053A2 (en) | 1977-06-07 | 1979-06-29 | Increasing antibacterial activity of cephalosporin derivs. - by combining with beta lactamase inhibiting penicillanic-S,S-di:oxide |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE2912511C2 (en) |
FR (1) | FR2442053A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1158639A (en) * | 1978-12-11 | 1983-12-13 | Eric M. Gordon | 6-bromopenicillanic acid sulfone |
IL61880A (en) * | 1980-01-21 | 1984-11-30 | Bristol Myers Co | 2beta-chloromethyl-2alpha-methylpenam-3alpha-carboxylic acid sulfone derivatives,their preparation and pharmaceutical compositions containing them |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5236684A (en) * | 1975-09-13 | 1977-03-22 | Toyama Chem Co Ltd | Process for preparation of novel penicillins and cephalosporins |
FR2393804A1 (en) * | 1977-06-07 | 1979-01-05 | Pfizer | 1,1-DIOXIDES OF PENICILLANIC ACID AND ITS ESTERS USEFUL AS B-LACTAMASE INHIBITORS |
FR2420347A1 (en) * | 1978-03-24 | 1979-10-19 | Toyama Chemical Co Ltd | NEW ANTIBACTERIAL COMPOSITION CONTAINING A CEPHALOSPORIN AND A B-LACTAMASE INHIBITOR COMPOUND CONTAINING A B-LACTAM CORE |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE41109B1 (en) * | 1974-04-20 | 1979-10-24 | Beecham Group Ltd | Novel -lactam antibiotic from streptomyces clavuligerus |
-
1979
- 1979-03-29 DE DE2912511A patent/DE2912511C2/en not_active Expired
- 1979-06-29 FR FR7917043A patent/FR2442053A2/en active Granted
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5236684A (en) * | 1975-09-13 | 1977-03-22 | Toyama Chem Co Ltd | Process for preparation of novel penicillins and cephalosporins |
FR2393804A1 (en) * | 1977-06-07 | 1979-01-05 | Pfizer | 1,1-DIOXIDES OF PENICILLANIC ACID AND ITS ESTERS USEFUL AS B-LACTAMASE INHIBITORS |
FR2420347A1 (en) * | 1978-03-24 | 1979-10-19 | Toyama Chemical Co Ltd | NEW ANTIBACTERIAL COMPOSITION CONTAINING A CEPHALOSPORIN AND A B-LACTAMASE INHIBITOR COMPOUND CONTAINING A B-LACTAM CORE |
Non-Patent Citations (1)
Title |
---|
CA1977 * |
Also Published As
Publication number | Publication date |
---|---|
DE2912511A1 (en) | 1979-10-04 |
DE2912511C2 (en) | 1982-06-24 |
FR2442053B2 (en) | 1982-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2000138A (en) | Therapeutic agents | |
IE782546L (en) | Amino-thiazolyl cephalosporins | |
FR2442053A2 (en) | Increasing antibacterial activity of cephalosporin derivs. - by combining with beta lactamase inhibiting penicillanic-S,S-di:oxide | |
ES8305769A1 (en) | Bis-esters of 1,1-alkanediols with 6-beta-hydroxymethylpenicillanic acid 1,1-dioxide and beta-lactam antibiotics. | |
JPS6440488A (en) | Cephalosporin derivative, manufacture, fungicidal medicine and intermediate | |
ES462012A1 (en) | 7-Substituted aminoacetamido oxadethiacephalosporins | |
SE8000512L (en) | SET TO MAKE PENICILLANIC ACID-1,1-DIOXIDE AND ESTABLISH THEREFORE INTERMEDIATE INTERMEDIATES FOR THE COMPLETION OF THE SET | |
JPS5799592A (en) | Novel cephalosporins | |
DE3166235D1 (en) | Beta-lactam antibacterial compounds, their preparation and pharmaceutical compositions containing them | |
ES429864A1 (en) | 1,4-Dihydro-4-oxo-pyridylacetamido cephalosporins and their utilization as medicinal agents for combating bacterial infections | |
Fleming et al. | Inhibition of Aerobacter cephalosporin β-lactamase by penicillins | |
FR2361893A2 (en) | Amino-thiazolyl-hydroxyimino-acetamido-cephalosporanic acids - with antibacterial activity | |
FR2368490A1 (en) | Amide analogues of clavulanic acid - useful as beta-lactamase inhibitors and antibiotics | |
SE444764B (en) | ANTI-BACTERIAL COMPOSITION FOR MEDICAL USE CONTAINING 6- / D (-) - ALFA- (4-ETHYL-2,3-DIOXO-1-PIPERAZINYL CARBONYLAMINO) PHENYLACETAMIDO / PENICILLANIC ACIDANE BETINETHYDE | |
ES8501405A1 (en) | Chemical compound | |
FR2422668A1 (en) | 3-Azido:methyl-3-cephem-4-carboxylic acid derivs. - useful as broad-spectrum antibacterial agents and disinfectants (BE 15.10.79) | |
FR2372630A1 (en) | Antibacterial cephalosporin type cpds - eg 7-beta-(substd-acetamido)-3-(3-heterocyclyl prop-1-enyl)-ceph-3-em-4-carboxylic acids | |
FR2278698B1 (en) | ||
IT1036078B (en) | Beta-Lactam antibiotic combination preparations - contg a 7-tetrazolylacetamido-cephem cpd and penicillin | |
ES482194A1 (en) | Cephalosporin derivatives, processes for their preparation and pharmaceutical compositions containing them. | |
ES8200371A1 (en) | N-substituted thiazolyl derivatives of oxy-imino-substituted cephalosporins useful as anti-bacterial agents | |
FR2285134A1 (en) | 7-(2-(4-hydroxy-3-nitrophenyl)-2-aminoacetamido)-cephalosporins - with broad-spectrum antibacterial activity | |
GB1067644A (en) | Antibiotic cephalosporin compounds and process for preparing same | |
KR900005050B1 (en) | 6-beta (substituted)-(s)-hydroxymethyl-penicillanic acids and derivatives thereof | |
JPS565484A (en) | Cephalosporin derivative and its salt |